Altered Aortic Hemodynamics and Relative Pressure in Patients with Dilated Cardiomyopathy

David Marlevi1,2,3, Jorge Mariscal-Harana4, Nicholas S Burris5

  • 1Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA, USA.

Insights

Dilated cardiomyopathy (DCM) patients show altered aortic function, including reduced pressure and increased stiffness. Advanced imaging reveals key hemodynamic changes in DCM, offering new diagnostic insights beyond traditional biomarkers.

Area of Science:

  • Cardiovascular Imaging and Hemodynamics
  • Cardiology
  • Biomedical Engineering

Background:

  • Ventricular-vascular interaction is crucial in cardiovascular disease adaptation.
  • Current monitoring of cardiomyopathy patients relies heavily on cardiac biomarkers.
  • Aortic function assessment is underexplored in dilated cardiomyopathy (DCM).

Purpose of the Study:

  • To investigate aortic function in patients with idiopathic dilated cardiomyopathy (DCM).
  • To explore the relationship between ventricular function and aortic hemodynamics in DCM.
  • To establish advanced imaging as a tool for understanding DCM manifestation.

Main Methods:

  • Cardiac magnetic resonance imaging (CMR) was performed on 14 DCM patients and 16 controls.
  • Physics-based image processing was used to derive aortic relative pressure.
  • A virtual cohort was employed to analyze the impact of cardiovascular properties on aortic behavior.

Main Results:

  • DCM patients with reduced left ventricular systolic function exhibited significantly lower aortic relative pressure.
  • Increased aortic stiffness and delayed time-to-pressure peak duration were observed in DCM patients.
  • Aortic stiffness and volumetric size were identified as primary determinants of aortic relative pressure in the virtual cohort.

Conclusions:

  • Advanced flow imaging and hemodynamic evaluation offer novel insights into DCM.
  • The study demonstrates altered aortic structure and function in DCM using a proposed imaging protocol.
  • This approach could complement cardiac biomarkers for improved DCM monitoring and understanding.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
96
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
60
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.6K
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
66
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
61
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
471